A detailed history of Northern Trust Corp transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 36,848 shares of SNTI stock, worth $80,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,848
Previous 36,848 -0.0%
Holding current value
$80,697
Previous $14,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.15 - $2.06 $25,934 - $46,457
22,552 Added 157.75%
36,848 $43,000
Q3 2022

Nov 14, 2022

BUY
$1.33 - $21.7 $19,013 - $310,223
14,296 New
14,296 $31,000

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $95.8M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.